March 11, 2010
Panel to discuss health care impact of genetic discoveries
A panel discussion on “New Discoveries in Medicine: Implications for the Cost and Quality of American Health Care” will be presented from 7:30 to 9:30 p.m. Tuesday, April 6, in Kane Hall.
The event is free and open to the general public. It is being held in conjunction with the UW Department of Genome Sciences’ Ninth Annual Symposium.
The panelists are leading thinkers in health care and medical research:
- Eric Larson, executive director and senior investigator at Group Health Cooperative, Seattle;
- Barbara McNeil, professor and head of the Department of Health Care Policy, Harvard University;
- Paul Ramsey, chief executive officer of UW Medicine, executive vice president for medical affairs and dean of the School of Medicine, UW; and
- Roger Perlmutter, executive vice president of research and development, Amgen Corporation, Thousand Oaks, Calif.
The panel will be moderated by Jay Shendure, UW assistant professor of genome sciences.
The Genome Sciences Symposium will take place the next day at the UW Health Sciences Center.
The theme will be “New Technologies for Early Detection and Diagnosis of Disease.” A series of scientific talks will be given from 9 a.m. to 5 p.m. Wednesday, April 7, in Hogness Auditorium, A-420 Health Sciences Bldg.
The speakers will be:
- Ruedi Aebersold, Institute of Molecular Systems Biology, Zurich, Switzerland;
- Richard Caprioli, Vanderbilt University School of Medicine;
- Robert Gerszten, Massachusetts General Hospital Division of Cardiology and Center for Immunology and Inflammatory Diseases;
- Joshua LaBaer, Biodesign Institute, Arizona State University;
- Elaine Mardis, Washington University Genome Sequencing Center;
- Amanda G. Paulovich, Fred Hutchinson Cancer Research Center; and
- Stephen Quake, Stanford University and Howard Hughes Medical Institute.
For more information, please contact Carlene Cross at 206-221-5374.
